What Is Evista?
hydrochloride) is a prescription medication approved for the following uses:
- Preventing and treating osteoporosis in postmenopausal women
- Reducing the risk of breast cancer in postmenopausal women with osteoporosis
- Reducing the risk of breast cancer in postmenopausal women who are at high risk for it.
Who Makes Evista?
Evista is made by Eli Lilly and Company.
How Does It Work?
Evista belongs to a group of medications called selective estrogen receptor modulators (SERMs). SERMs have both estrogenic (estrogen-like) effects and anti-estrogen effects. Evista has anti-estrogen effects on the breasts, while it has estrogen-like effects on bones (helping to strengthen them).
Many breast cancers are sensitive to the estrogen hormone, meaning that the tumor grows with the help of it. Evista binds to estrogen receptors in the breast, preventing the hormone from binding. By decreasing the effects of estrogen, Evista can help reduce the risk of developing breast cancer.
Evista has been evaluated in several studies for various uses.